Obefazimod Induction Treatment for Ulcerative Colitis

Obefazimod Induction Treatment for Ulcerative Colitis
90%69%48%Apr 26Apr 27Apr 28Apr 29Apr 30May 1May 2May 3May 4May 5May 6May 7May 8May 9May 10May 11May 12May 13Apr 26 • YES 55.0%Apr 27 • YES 67.0%Apr 28 • YES 67.0%Apr 29 • YES 67.0%Apr 30 • YES 67.0%May 1 • YES 67.0%May 2 • YES 67.0%May 3 • YES 67.0%May 4 • YES 67.0%May 5 • YES 67.0%May 6 • YES 55.4%May 7 • YES 61.5%May 9 • YES 65.5%May 11 • YES 77.5%May 12 • YES 82.5%May 13 • YES 82.9%
Abivax S.A. ($ABVX)
No stock closeNo stock close$129.8$116.4$103.0Apr 26Apr 27Apr 28Apr 29Apr 30May 1May 2May 3May 4May 5May 6May 7May 8May 9May 10May 11May 12May 13Apr 27 • ABVX $111.9Apr 28 • ABVX $109.9Apr 29 • ABVX $106.2Apr 30 • ABVX $117.4May 1 • ABVX $117.6May 4 • ABVX $117.1May 5 • ABVX $123.8May 6 • ABVX $126.5May 7 • ABVX $124.7May 8 • ABVX $122.7May 11 • ABVX $122.1May 12 • ABVX $121.4May 13 • ABVX $121.9

Will this trial show a positive result on clinical remission at 8 weeks based on the Modified Mayo Score?

Paper Trading
Create account to trade
ClinicalTrialModel PositionsModel ReasoningOracle
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs